Forbes April 28, 2024
The World Health Organization estimates that at least one-third of the world’s population does not have access to essential medicines, resulting in millions of avoidable deaths each year from infectious diseases including malaria, tuberculosis, and HIV. Barriers to access to these medicines disproportionately affect people in low- and middle-income countries (LMICs) due to unaffordable drug prices, drug shortages, and poor distribution and manufacturing infrastructure. If the world is going to achieve global equity in drug access, and therefore decrease inequities in disease, these countries must be able to not only afford the drugs but deliver them to those who need them the most.
Affording the Drugs
Frequent shortages in drug supply highlight the need for better access to life saving...
Today's Sponsors
Today's Sponsor